1. Farrand KF, Fridman M, et al. Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older. Am J Ophthalmol 2017; 182:90–98.
2. Kim M, Oh JH, et al. Dry eye disease and allergic conditions: A Korean nationwide population-based study. Am J Rhinol Allergy 2016;30(6):397–401.
3. Galor A, Feuer W, et al. Depression, post-traumatic stress disorder, and dry eye syndrome: a study utilizing the national United States Veterans Affairs administrative database. Am J Ophthalmol 2012;154(2):340–346.e342.
4. Wang T-J, Wang I-J, et al. Comorbidities of dry eye disease: a nationwide population-based study. Acta Ophthalmol 2012;90(7):663–668.
5. Semp DA, Beeson D, et al. Artificial Tears: A Systematic Review. Clin Optom (Auckl). 2023 Jan 10;15:9-27. doi: 10.2147/OPTO.S350185. PMID: 36647552; PMCID: PMC9840372.
6. Nichols JJ, Willcox MD, et al. The TFOS International Workshop on Contact Lens Discomfort: executive summary. Invest Ophthalmol Vis Sci. 2013; 54: TFOS7–TFOS13.
7. Geerling G, Tauber J, et al. The international workshop on meibomian gland dysfunction: Report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2011;52(4):2050- 64.
8. Craig JP, Nichols KK, et al. TFOS DEWS II Definition and Classification Report. Ocul Surf 2017;15(3): 276–283.
9. Tsubota K, Yokoi N, et al. New perspectives on dry eye definition and diagnosis: A consensus report by the Asia dry eye society. The Ocular Surface 2017;15(1):65-76.
10. Baudouin C, Aragona P, et al. Diagnosing the severity of dry eye: A clear and practical algorithm. Br J Ophthalmol. 2014;98(9):1168-76. doi: 10.1136/bjophthalmol-2013-304619.
11. Messmer EM. The pathophysiology, diagnosis and treatment of dry eye disease. Dtsch Arztebl Int. 2015;112:71-82.
12. Milner MS, Beckman KA, et al. Dysfunctional tear syndrome: Dry eye disease and associated tear film disorders – New strategies for diagnosis and treatment. Curr Opin Ophthalmol. 2017;27:3-47. doi: 10.1097/01.icu.0000512373.81749.b7.
13. Shtein, RM., et.al. Autologous Serum-Based Eye Drops for Treatment of Ocular Surface Disease. Ophthalmology 2020;127:128-133
14. Tong L, Petznick A, Lee SY. Assessment and Management of Dry Eye Patients for Non-Ophthalmic Healtcare Practitioners. Proceedings of Singapore Healthcare.2012;Vol.21 (1).
15. Aguilar AJ, Marquez MI, et al. Effects of Systane(®) Balance on noninvasive tear film break-up time in patients with lipid deficient dry eye. Clinical Ophthalmology. 2014; 8:2365–72.
16. Comez AT, Tufan HA, et al. Effects of lubricating agents with different osmolalities on tear osmolarity and other tear function tests in patients with dry eye. Current Eye Research. 2013; 38(11):1095–103.
17. Simmons PA, Vehige JG. Clinical performance of a mid viscosity artificial tear for dry eye treatment. Cornea. 2007; 26(3):294–302.
18. Simmons PA, Carlisle-Wilcox C, et al. Comparison of novel lipid-based eye drops with aqueous eye drops for dry eye: a multicenter, randomized controlled trial. Clinical Ophthalmology. 2015; 9:657–64.
19. Pucker A D, Sueko M N, et al. Over the counter (OTC) artificial tear drops for dry eye syndrome. Cochrane Database Syst Rev. ; 2: CD009729. 2016. doi:10.1002/14651858.CD009729.pub2.
20. Li Y, Cui L, et al. Comparison of 0.3% hypotonic and isotonic sodium hyaluronate eye drops in the treatment of experimental dry eye. Curr Eye Res. 2017;42(8):1108-14. doi: 10.1080/02713683.2017.1297462
21. Fukuoka S, Arita R. Increase in tear film lipid layer thickness after installation of 3% diquafosol ophthalmic solution in healthy human eyes. Ocul Surf. 2017;15(4):730- 5. doi: 10.1016/j.jtos.2017.03.005